These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8737862)

  • 21. Interplay between superantigens and the immune system.
    Irwin MJ; Gascoigne NR
    J Leukoc Biol; 1993 Nov; 54(5):495-503. PubMed ID: 8228628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell allorecognition of HLA class II.
    Termijtelen A
    Hum Immunol; 1990 May; 28(1):1-10. PubMed ID: 2187838
    [No Abstract]   [Full Text] [Related]  

  • 23. The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines.
    Germain RN
    Ann N Y Acad Sci; 1995 May; 754():114-25. PubMed ID: 7625645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nature of allorecognition.
    Krensky AM; Clayberger C
    Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):898-903. PubMed ID: 7922230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and cellular biology of antigen processing and presentation.
    Yewdell J
    Cancer Cells; 1991 Jul; 3(7):278-82. PubMed ID: 1911041
    [No Abstract]   [Full Text] [Related]  

  • 26. The regulation of expression of histocompatibility antigens on the cell surface; molecular genetic basis.
    Petrányi GG
    Folia Biol (Praha); 1995; 41(3-4):163-77. PubMed ID: 7589712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
    Holling TM; Schooten E; van Den Elsen PJ
    Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides.
    Rock KL; Rothstein LE; Gamble SR; Benacerraf B
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7517-21. PubMed ID: 2217182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules.
    McConnell HM; Wada HG; Arimilli S; Fok KS; Nag B
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2750-4. PubMed ID: 7708718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immune response to kidney allograft. Part I: the role of MHC antigens, antigen-presenting cells, and lymphocytes in alloantigen recognition; two-signal activation of T cells].
    Kusztal M; Jezior D; Weyde W; Krajewska M; Klinger M
    Postepy Hig Med Dosw (Online); 2007; 61():13-20. PubMed ID: 17245313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ligands of the class II major histocompatibility complex-restricted T cells.
    Demotz S
    Chem Immunol; 1993; 57():18-38. PubMed ID: 7505087
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigen processing: a critical factor in rational vaccine design.
    Yewdell JW; Bennink JR
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):26-32; discussion 33-4. PubMed ID: 8303307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
    Ladel CH; Daugelat S; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qa-1 restricted recognition of foreign antigen by a gamma delta T-cell hybridoma.
    Vidović D; Roglić M; McKune K; Guerder S; MacKay C; Dembić Z
    Nature; 1989 Aug; 340(6235):646-50. PubMed ID: 2528072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phagocytosis and antigen presentation.
    Watts C; Amigorena S
    Semin Immunol; 2001 Dec; 13(6):373-9. PubMed ID: 11708893
    [No Abstract]   [Full Text] [Related]  

  • 36. Structure of peptides associated with class I and class II MHC molecules.
    Engelhard VH
    Annu Rev Immunol; 1994; 12():181-207. PubMed ID: 7516668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules.
    Adorini L; Appella E; Doria G; Cardinaux F; Nagy ZA
    Nature; 1989 Dec; 342(6251):800-3. PubMed ID: 2513490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use.
    Engelhard VH; Bullock TN; Colella TA; Mullins DW
    Cancer J; 2000 May; 6 Suppl 3():S272-80. PubMed ID: 10874498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presentation of antigenic peptides by products of the major histocompatibility complex.
    Fairchild PJ
    J Pept Sci; 1998 May; 4(3):182-94. PubMed ID: 9643627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S; Humphreys RE
    Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.